Enveda, an AI drugmaker, banks $311M in venture funding

Enveda, which is using AI tools to mine plants and microbes for drug prospects, has three candidates in human testing for immune diseases and obesity.

Summary from BioPharma Dive.

Coverage 1 article · 1 outlet

1. BioPharma Dive yesterday
   Enveda, an AI drugmaker, banks $311M in venture funding ↗